Full Market Visibility Is Crucial for Winning Deals: What PE Firms Need to Know Now 
JS Global Announces 2025 Annual Results, Adjusted Net Profit Up 338% 
From Sell-Down Overhang to Heavy Institutional Holdings: Shoucheng Holdings (0697.HK) Upgrades Its Shareholder Structure and Opens the Door to Value Re-Rating 
Sigenergy Passes Hearing: “AI + Energy Storage” Driving a 150-fold Revenue Surge and Redefining Industry Growth Coherus BioSciences Announces New Employment Inducement Grants
REDWOOD CITY, Calif., April 30, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus” or the…
ObsEva SA presents posters at the ACOG Annual Clinical and Scientific Virtual Meeting April 30 – May 2, 2021
GENEVA, Switzerland and BOSTON, MA – April 30, 2021 – ObsEva SA (NASDAQ: OBSV /…
Progenity Presents Key Verification Study Data for Preecludia™ Preeclampsia Rule-out Test at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting
Data demonstrate strong sensitivity and negative predictive value (NPV) SAN DIEGO, April 30, 2021 (GLOBE…
Galapagos creates new subscription right plans
Mechelen, Belgium; 30 April 2021, 22.01 CET; regulated information –– Galapagos NV (Euronext & NASDAQ: GLPG)…
PCI Biotech: First US patient enrolled in the fimaChem pivotal RELEASE study
Oslo (Norway), 30 April 2021 – PCI Biotech (OSE: PCIB), a clinical-stage biopharma company developing…
Annual General Meeting of April 30, 2021
Annual General Meeting of April 30, 2021 Approval of the financial statements for the fiscal…
Santhera Completes Capital Increases for Financing Arrangements
Pratteln, Switzerland, April 30, 2021 – Santhera Pharmaceuticals (SIX: SANN) announces that it has issued 2,312,000…
22nd Century Group Welcomes Ban on Menthol Cigarettes and Anticipates Further Standards as FDA Commissioner Reports Nicotine Cap on Combustibles “Still on the Table”
Applauds Decisive Move and Commitment by FDA to Advance Rule Banning Menthol As First Step…
Agile Therapeutics Announces Presentation of Safety and Efficacy Data of Twirla® (Levonorgestrel and Ethinyl Estradiol) Transdermal System in Women of Differing BMI Categories at ACOG Annual Meeting
PRINCETON, N.J., April 30, 2021 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare…
Axiom Presents “Unified Platforms: Benefits and considerations when running global studies” at Outsourcing in Clinical Trials Europe 2021
LONDON, April 30, 2021 (GLOBE NEWSWIRE) — Axiom Real-Time Metrics (“Axiom”), premier provider of unified…
Rafarma and Haifa Technopark Enter Talks for Joint Venture
Rafarma Pharmaceuticals, Inc. Matam Technopark in Haifa Israel Nicosia, Cyprus, April 30, 2021 (GLOBE NEWSWIRE)…
Polydex Pharmaceuticals Issues Year End Financial Results
Company Remains Profitable in Global Pandemic TORONTO, April 30, 2021 (GLOBE NEWSWIRE) — Polydex Pharmaceuticals…
BioCryst Receives European Commission Approval of ORLADEYO™ (berotralstat), First Oral, Once-daily Therapy to Prevent Attacks in Hereditary Angioedema Patients
RESEARCH TRIANGLE PARK, N.C., April 30, 2021 (GLOBE NEWSWIRE) — BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX)…
Praxis Precision Medicines Receives Orphan Drug Designation for PRAX-562 for the Treatment of SCN2A-DEE
PRAX-562 Phase 2 clinical trial for treatment of DEEs expected to initiate in first half…
Coherus BioSciences to Report First Quarter 2021 Financial Results on May 6th
REDWOOD CITY, Calif., April 30, 2021 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus” or “the…
SCYNEXIS Presents Data at 2021 ACOG Demonstrating the Positive Outcome and Sustained Response of Investigational Oral Ibrexafungerp (Brexafemme™) in Difficult-to-Treat Patients with Vaginal Yeast Infections
A single-day dose of oral ibrexafungerp demonstrates positive clinical outcomes in difficult-to-treat vulvovaginal candidiasis (VVC)…
Kinnate Biopharma Inc. Announces the Departure of Dr. Stephen Kaldor from its Board of Directors
SAN FRANCISCO and SAN DIEGO, April 30, 2021 (GLOBE NEWSWIRE) — Kinnate Biopharma Inc. (Nasdaq:…
Oyster Point Pharma to Report First Quarter 2021 Financial Results on May 6, 2021
Conference Call and Webcast Scheduled for May 6, 2021, 4:30 p.m. Eastern Time PRINCETON, N.J.,…
AnPac Bio Reports Fiscal Year 2020 Annual Financial Results (89.1% Increase in Revenue and 20.7% Decrease in Net Loss)
SAN JOSE, Calif., April 30, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac…